Advisory Services Network, LLC Intercept Pharmaceuticals, Inc. Transaction History

Advisory Services Network, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	SELL	$12.99 - $20.47 $27,279 - $42,987	-2,100 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$15.46 - $24.5 $32,466 - $51,450	2,100 New	2,100 $42,000
Q1 2021 May 24, 2021	SELL	$19.33 - $37.75 $24,645 - $48,131	-1,275 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$24.48 - $42.47 $26,316 - $45,655	1,075 Added 537.5%	1,275 $31,000
Q3 2020 Nov 16, 2020	BUY	$39.09 - $53.44 $7,818 - $10,688	200 New	200 $8,000
Q1 2019 May 20, 2019	SELL	$91.83 - $120.68 $27,824 - $36,566	-303 Closed	0 $0
Q4 2018 Feb 15, 2019	SELL	$85.79 - $126.46 $271,782 - $400,625	-3,168 Reduced 91.27%	303 $31,000
Q3 2018 Nov 02, 2018	BUY	$88.49 - $127.55 $307,148 - $442,726	3,471 New	3,471 $439,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.